GoC Yields Tip Back Towards Session Lows

GoC Yields Tip Back Towards Session Lows

GoC yields tipped back towards session lows alongside Treasuries, as risk assets were further underpinned following news U.S. President Donald Trump plans to decertify the Iran nuclear pact. Treasury yields had plunged early in the session on the tame core consumer price index print, with GoCs following suit. The S&P/TSX continues to outperform Wall Street thanks to firmer crude oil prices, up 0.5% compared to 0.2% gains for the Dow […]

Read More ˃
Net Element Shares Surge 45% After Reporting Strong Growth in Its North America Unified Payments Ops

Net Element Shares Surge 45% After Reporting Strong Growth in Its North America Unified Payments Ops

Net Element (NETE) shares surged 45% Friday after the provider of solutions for electronic payments acceptance across point of sale, e-commerce and mobile devices reported strong growth in its North America Unified Payments division. Total e-commerce volumes in H1 increased by 33% from a year ago and transactions processed increased by 34%. New e-commerce merchants in H1 increased by 37%.. Total volumes for electronic commerce and value-added integrated services such […]

Read More ˃
Goldman Reportedly Is Looking Into Options for Its Less Than $1 Mln Stake in Harvey Weinstein’s Film Studio

Goldman Reportedly Is Looking Into Options for Its Less Than $1 Mln Stake in Harvey Weinstein’s Film Studio

Goldman Sachs (GS) is weighing its options for its less-than $1 million stake in Weinstein and Co., Harvey Weinstein’s film studio that it co-founded with his brother Bob, Bloomberg reported, citing the Wall Street bank’s spokesman Andrew Williams. Harvey Weinstein was sacked from the studio after allegations that he had sexually harassed and assaulted women over decades, according to recent news reports. Goldman was an initial investor in the studio […]

Read More ˃
Forum Energy Cuts Q3 Outlook Due to Harvey Impact

Forum Energy Cuts Q3 Outlook Due to Harvey Impact

Forum Energy Technologies (FET) said Thursday that its Q3 financial results were adversely impacted by Hurricane Harvey’s widespread damage in Texas and Louisiana, and now expects revenues of approximately $200 million and adjusted net loss of $0.10 per share for the quarter. The company previously issued net loss guidance of $0.07 to $0.04 loss per share, on sequential revenue growth of 8% to 12%. Analysts polled by Capital IQ have […]

Read More ˃
Micron Technology Prices Upsized Offering of 29.3 Mln Shares at 1.5% Discount

Micron Technology Prices Upsized Offering of 29.3 Mln Shares at 1.5% Discount

Micron Technology (MU) said late Wednesday it has priced the sale of 29.3 million shares in a public offering at $41 each, a 1.5% discount to the closing price. The offering was upsized to $1.2 billion from previously $1 billion. Micron also granted the underwriter an option to buy an additional 4.4 million shares. The company said it plans to use approximately $476 million of the net proceeds to redeem […]

Read More ˃
DXC Technology to Combine US Public Sector Ops With Vencore

DXC Technology to Combine US Public Sector Ops With Vencore

DXC Technology (DXC) said late Thursday it plans to combine its US Public Sector business with Vencore Holding Corporation and KeyPoint Government Solutions to form a separate, independently publicly traded company that will serve US public sector clients. Under the agreement, DXC shareholders will own approximately 86% of the new company and private equity firm Veritas Capital and its affiliates, which own Vencore and KeyPoint, will own 14% and will […]

Read More ˃
Protagonist Therapeutics Prices Offering of 3.5 Mln Shares at 14.2% Discount

Protagonist Therapeutics Prices Offering of 3.5 Mln Shares at 14.2% Discount

Protagonist Therapeutics (PTGX) said late Wednesday it has priced the public offering of more than 3.5 million shares at $17 each, a 14.2% discount to the closing price. The company has also granted underwriters a 30-day option to buy an additional 529,500 shares. Gross proceeds are expected to be $60 million and Protagonist said it plans to use net proceeds to fund clinical research and development of the company’s three […]

Read More ˃
Equities Futures Near Flat After Another Record

Equities Futures Near Flat After Another Record

US equities futures were hovering around unchanged early Thursday after the benchmark indices touched new records Wednesday. Overseas, investors are watching Spain and the fallout from Catalonia’s independence vote. Minutes from the last European Central Bank meeting are released Thursday. The US dollar was off against the euro, the Japanese yen and the Canadian dollar but higher against the pound sterling. – The S&P 500 future was down 0.09% recently, […]

Read More ˃
Organovo Holdings Preliminary Fiscal Q2 Sales Slip From Year Ago & Lag Forecast

Organovo Holdings Preliminary Fiscal Q2 Sales Slip From Year Ago & Lag Forecast

Organovo Holdings (ONVO) reported late Wednesday preliminary fiscal Q2 total revenue is expected to be between $1.3 million and $1.4 million. At the midpoint, this result reflects a 2% decrease from a year ago and a 36% surge sequentially. The average analyst forecast for the sales is $1.46 million. Shares gained 1.5% in after-hours trading. The company said in a statement it sees a strong possibility of one or more […]

Read More ˃
MutualFirst Financial and Universal Bancorp Sign Merger Deal to Expand Footprint in Central & Southern Indiana

MutualFirst Financial and Universal Bancorp Sign Merger Deal to Expand Footprint in Central & Southern Indiana

MutualFirst Financial (MFSF) and Universal Bancorp said late Wednesday they signed an agreement pursuant to which Universal will be merged into MutualFirst, with MutualFirst being the surviving entity. The cash and stock transaction is valued at about $65.6 million. After the close, BloomBank, a wholly owned subsidiary of Universal, will merge into MutualFirst’s wholly owned bank subsidiary, MutualBank, according to a statement. The merger is expected to be accretive to […]

Read More ˃
Globalstar to Sell $125 Mln in Shares of Voting Common Stock

Globalstar to Sell $125 Mln in Shares of Voting Common Stock

Globalstar (GSAT), a provider of mobile satellite voice and data services, said after market close on Wednesday that it has begun an offering of $125 million in shares of voting common stock in a registered underwritten public offering. Globalstar will grant the underwriters a 30-day option to buy up to $18.75 million in additional shares of voting common stock. This offering is made to satisfy a requirement relating to the […]

Read More ˃
Equities Build on Rallies in US With More Record Highs

Equities Build on Rallies in US With More Record Highs

Markets in the US ended firmer, with gains in all indices sending them to record highs for another day as economic data bolstered investor sentiment and helped reverse earlier losses. Utilities surged 1.1% to post the best increase on the Standard & Poor’s 500, with six of the 11 sectors gaining. On the downside, financials fell 0.3% and energy shed 0.1% as crude oil prices decreased. While the gains weren’t […]

Read More ˃
NextEra Energy Partners Sells $300 Mln of 1.5% Convertible Senior Notes Due 2020

NextEra Energy Partners Sells $300 Mln of 1.5% Convertible Senior Notes Due 2020

NextEra Energy Partners (NEP) said pre-market Monday that it has completed the placement and has closed the sale of $300 million of its 1.50% convertible senior notes due 2020 in a private placement to qualified institutional buyers. “This offering further demonstrates NextEra Energy Partners’ ability to tap into new sources of capital and is expected to enable the partnership to complete our growth funding for the year,” CEO Jim Robo […]

Read More ˃
Intellia Therapeutics Downgraded to Neutral by Chardan, Price Target Kept at $20/Share

Intellia Therapeutics Downgraded to Neutral by Chardan, Price Target Kept at $20/Share

Intellia Therapeutics (NTLA) received an investment-rating downgrade Tuesday to neutral from buy from Chardan Capital Markets, which cited the outperformance this year of the genome-editing company’s shares versus peers while saying the firm still has a positive bias on the stock. Chardan kept its price target on the shares at $20 per share, which is slightly below the stock’s Monday closing price of $20.82. The shares jumped 19% in Monday’s […]

Read More ˃
European ADRs Move Higher in Monday Trading

European ADRs Move Higher in Monday Trading

American depositary receipts of European stocks were trading 0.28% higher at 134.73 on the Bank of New York Mellon Europe ADR Index on Monday. In continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS), and medical equipment company Edap (EDAP), which rose 10.7% and 1.8% respectively. They were followed by healthcare company Novo Nordisk (NVO), and biopharmaceutical company Forward Pharma (FWP), which were up 1.2% and 1%. The […]

Read More ˃
Global Blood Therapeutics Files for Sale of of Securities

Global Blood Therapeutics Files for Sale of of Securities

Global Blood Therapeutics said Thursday in a Securities and Exchange Commission filing that it may from time to time sell as much as $125 million worth of securities. The securities may include common stock, preferred stock, debt securities, warrants and/or units, it said. It may offer these securities separately or together in units, it said. The shares were down 1.5% in early trading on Thursday.

Read More ˃